Citations

Citations to this article as recorded by  

• Inflammatory Bowel Disease – Non-biological treatment
  Fernando Magro, Gonçalo Cordeiro, Andreia Martins Dias, Maria Manuela Estevinho
  Pharmacological Research.2020; 160: 105075.     CrossRef

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease of the gastrointestinal tract, with increasing prevalence worldwide. IBD Ahead is an international educational program that aims to explore questions commonly raised by clinicians about various areas of IBD care and to consolidate available published evidence and expert opinion into a consensus for the optimization of IBD management. Given differences in the epidemiology, clinical and genetic characteristics, management, and prognosis of IBD between patients in Japan and the rest of the world, this statement was formulated as the result of literature reviews and discussions among Japanese experts as part of the IBD Ahead program to consolidate statements of factors for disease prognosis in IBD. Evidence levels were assigned to summary statements in the following categories: disease progression in CD and UC; surgery, hospitalization, intestinal failure, and permanent stoma in CD; acute severe UC; colectomy in UC; and colorectal carcinoma and dysplasia in IBD. The goal is that this statement can aid in the optimization of the treatment strategy for Japanese patients with IBD and help identify high-risk patients that require early intervention, to provide a better long-term prognosis in these patients.

Citations

Citations to this article as recorded by  

• Precision medicine in inflammatory bowel diseases
  Ashwin N. Ananthakrishnan
  Intestinal Research.2024; 22(1): 8.     CrossRef
• Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease
  Hiromu Morikubo, Takayoshi Nagahama, Katsuhiko Nagai, Hajime Yamazaki, Taku Kobayashi
  Inflammatory Intestinal Diseases.2024; 9(1): 260.     CrossRef
• A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
  Yanfang Liu, Choo Hua Goh, Hong Qiu, Kuan-Chih Huang, Hsingwen Chung, Carine Saadoun
  Annals of Pharmacotherapy.2023; 57(9): 1053.     CrossRef
• Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis
  Kunio Asonuma, Taku Kobayashi, Masaru Nakano, Shintaro Sagami, Hiroki Kiyohara, Mao Matsubayashi, Hiromu Morikubo, Yusuke Miyatani, Shinji Okabayashi, Hajime Yamazaki, Yuichiro Kuroki, Toshifumi Hibi
  Inflammatory Bowel Diseases.2022; 28(2): 200.     CrossRef
• Intestinal cancer in patients with Crohn's disease: A systematic review and meta‐analysis
  Motoi Uchino, Hiroki Ikeuchi, Keisuke Hata, Tomohiro Minagawa, Yuki Horio, Ryuichi Kuwahara, Shiro Nakamura, Kenji Watanabe, Masayuki Saruta, Toshimitsu Fujii, Taku Kobayashi, Ken Sugimoto, Fumihito Hirai, Motohiro Esaki, Sakiko Hiraoka, Katsuyoshi Matsuo
  Journal of Gastroenterology and Hepatology.2021; 36(2): 329.     CrossRef
• MR-enterography in Crohn’s disease: what MRE mural parameters are associated to one-year therapeutic management outcome?
  Pier Paolo Mainenti, Fabiana Castiglione, Antonio Rispo, Ettore Laccetti, Salvatore Guarino, Valeria Romeo, Anna Testa, Leonardo Pace, Simone Maurea
  The British Journal of Radiology.2021;[Epub]     CrossRef
• Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn’s Disease: A Nationwide Population-Based Study
  Eun Mi Song, Ho-Su Lee, Ye-Jee Kim, Eun Hye Oh, Nam Seok Ham, Jeongseok Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu, Suk-Kyun Yang
  Digestive Diseases and Sciences.2020; 65(4): 1189.     CrossRef
• Passion fruit (Passiflora edulis) leaf aqueous extract ameliorates intestinal epithelial barrier dysfunction and reverts inflammatory parameters in Caco-2 cells monolayer
  Mônica Cristina Lopes do Carmo, Isabela Mateus Martins, Ana Elisa Ramos Magalhães, Mário Roberto Maróstica Júnior, Juliana Alves Macedo
  Food Research International.2020; 133: 109162.     CrossRef
• Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study
  Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki
  Intestinal Research.2019; 17(3): 375.     CrossRef

Inflammatory bowel disease (IBD) patients are a high-risk population for opportunistic infections. The IBD group of the Chinese Society of Gastroenterology of the Chinese Medical Association organized an expert group to discuss and develop this consensus opinion. This consensus opinion referenced clinical study results from China and other countries to provide guidance for clinical practices. Eight major topics, including cytomegalovirus infection, Epstein-Barr virus infection, viral hepatitis, bacterial infection, Mycobacterium tuberculosis infection, fungal infection, parasitic infection, and vaccines were introduced in this article.

Citations

Citations to this article as recorded by  

• Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea
  Ji Eun Na, Sung Hoon Jung, Arum Choi, Sukil Kim, Tae‐Oh Kim
  Mycoses.2024;[Epub]     CrossRef
• Analysis of current situation and influencing factors of marital adjustment in patients with Crohn’s disease and their spouses
  Ting Pan, Danlei Chen, Zhihui Yu, Qing Liu, Yan Chen, Ailing Zhang, Fang Kong
  Medicine.2024; 103(11): e37527.     CrossRef
• Opportunistic infections changed before and after SARS-CoV-2 infection in inflammatory bowel disease patients: a retrospective single-center study in China
  Zhenzhen Fan, He Zhou, Jiaqi Zhang, Xiaoning Liu, Tong Wu, Yanting Shi, Junchao Lin, Jie Liang
  Frontiers in Medicine.2024;[Epub]     CrossRef
• The Impact of Cytomegalovirus Infection on Ulcerative Colitis Relapse: A Multicenter Retrospective Cohort Study
  Linmei Xiao, Jingjing Ma, Ruidong Chen, Jie Chen, Qiang Wang, Nana Tang, Xiaojing Zhao, Hongjie Zhang, Chunhua Jiao
  Journal of Inflammation Research.2024; Volume 17: 9059.     CrossRef
• Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im
  Intestinal Research.2023; 21(3): 353.     CrossRef
• Absence of Oral Opportunistic Infections in Patients with Inflammatory Bowel Disease Receiving Anti-TNF-α and Anti-Integrin-α4β7 Therapy
  Ema Saltović, Brankica Mijandrušić-Sinčić, Alen Braut, Ivana Škrobonja, Ella Sever, Irena Glažar, Sonja Pezelj-Ribarić, Miranda Muhvić-Urek
  Dentistry Journal.2022; 10(3): 32.     CrossRef
• Can visceral adipose tissue and skeletal muscle predict recurrence of newly diagnosed Crohn’s disease in different treatments
  Zinan Zhang, Xiaoyu Yu, Ning Fang, Xiuyan Long, Xixian Ruan, Jianing Qiu, Sifan Tao, Pan Gong, Kai Nie, An Li, Xiaoyan Wang, Li Tian
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study
  Hong Yang, Zhihua Ran, Meng Jin, Jia-Ming Qian
  Gut and Liver.2022; 16(5): 726.     CrossRef
• Neurological presentations of inflammatory bowel diseases
  Yu. O. Shulpekova, V. U. Ablaev, I. V. Damulin
  Medical alphabet.2021; (3): 34.     CrossRef
• Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study
  Ido Veisman, Oranit Barzilay, Liora Bruckmayer, Ola Haj-Natour, Uri Kopylov, Rami Eliakim, Shomron Ben-Horin, Bella Ungar
  Journal of Clinical Medicine.2021; 10(18): 4265.     CrossRef
• Fucose Ameliorates Tritrichomonas sp.-Associated Illness in Antibiotic-Treated Muc2−/− Mice
  Kseniya M. Achasova, Elena N. Kozhevnikova, Mariya A. Borisova, Ekaterina A. Litvinova
  International Journal of Molecular Sciences.2021; 22(19): 10699.     CrossRef
• The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn’s Disease: 4 Years of Global Post-marketing Data
  Russell D Cohen, Fatima Bhayat, Aimee Blake, Simon Travis
  Journal of Crohn's and Colitis.2020; 14(2): 192.     CrossRef
• Chronic Diarrhea in Children: Causes, Mechanisms, Primary Diagnostics and Management
  Dmitriy V. Pechkurov, Alena A. Tyazheva
  Current Pediatrics.2020; 18(6): 416.     CrossRef
• Chronic Diarrhea in Children: Causes, Mechanisms, Primary Diagnostics and Management
  Dmitriy V. Pechkurov, Alena A. Tyazheva
  Current Pediatrics.2020; 18(6): 416.     CrossRef
• Review article: managing the adverse events caused by anti‐TNF therapy in inflammatory bowel disease
  Uday N. Shivaji, Caroline L. Sharratt, Tom Thomas, Samuel C. L. Smith, Marietta Iacucci, Gordon W. Moran, Subrata Ghosh, Neeraj Bhala
  Alimentary Pharmacology & Therapeutics.2019; 49(6): 664.     CrossRef
• CYTOMEGALOVIRUS INFECTION IN INFLAMMATORY BOWEL DISEASES
  I. L. Khalif, T. L. Alexandrov, L. B. Kisteneva
  Koloproktologia.2019; 18(1(67)): 119.     CrossRef
• The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo
  Shian-Ren Lin, Chia-Hsiang Chang, May-Jwan Tsai, Henrich Cheng, Jian-Chyi Chen, Max K. Leong, Ching-Feng Weng
  Therapeutic Advances in Chronic Disease.2019;[Epub]     CrossRef
• A rare case of disseminated histoplasmosis in a patient with Crohn’s disease on immunosuppressive treatment
  Bhavesh Bhut, Akshay Kulkarni, Varnika Rai, Vinita Agrawal, Abhai Verma, Manoj Jain, Rungmei S K Marak, Ajai Kumar Dixit, Uday C Ghoshal
  Indian Journal of Gastroenterology.2018; 37(5): 472.     CrossRef
• The importance of immunization in immune-mediated inflammatory disease cannot be overstated
  Sang Hyoung Park
  Intestinal Research.2018; 16(3): 325.     CrossRef

The incidence and prevalence of inflammatory bowel disease (IBD) is increasing, and considering the aging population, this number is set to increase further in the future. The clinical features and natural history of elderly-onset IBD have many similarities with those of IBD in younger patients, but with significant differences including a broader differential diagnosis. The relative lack of data specific to elderly patients with IBD, often stemming from their typical exclusion from clinical trials, has made clinical decision-making somewhat challenging. Treatment decisions in elderly patients with IBD must take into account age-specific concerns such as comorbidities, locomotor and cognitive function, and polypharmacy, to set realistic treatment targets in order to enable personalized treatment and minimize harm. Notwithstanding paucity of clinical data, recent studies have provided valuable insights, which, taken together with information gleaned from previous studies, can broaden our understanding of IBD. These insights may contribute to the development of paradigms for the holistic and, when possible, evidence-based management of this potentially vulnerable population and are the focus of this review.

Citations

Citations to this article as recorded by  

• Older Adults with Inflammatory Bowel Disease Epidemiology in the United States: 2000–2021
  Pojsakorn Danpanichkul, Yanfang Pang, Chawinthorn Vuthithammee, Disatorn Dejvajara, Priyata Dutta, Passisd Laoveeravat, Omar Al Ta’ani, Agnes HY. Ho, Chun Wei Pan, Nicole Shu Ying Tang, Kanokphong Suparan, Rashid N. Lui, Donghee Kim, Siew C. Ng, Gursimran
  Digestive Diseases and Sciences.2025;[Epub]     CrossRef
• Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a meta-analysis on a global scale
  Khushbu Viresh Janani, Parsa Saberian, Hardik B. Patel, Narsimha Rao Keetha, Ardalan Etemadzadeh, Anya Patel, Seyyed Mohammad Hashemi, Ehsan Amini-Salehi, Anoop Gurram
  Journal of Health, Population and Nutrition.2025;[Epub]     CrossRef
• Fatigue, sarcopenia, and frailty in older adults with inflammatory bowel disease
  Federica BELLONE, Alberto SARDELLA, Marco MUSCIANISI, Giorgio BASILE
  Minerva Gastroenterology.2024;[Epub]     CrossRef
• Histology of IBD and related colitides in the elderly
  Giuseppe LEONCINI, Luca REGGIANI-BONETTI, Gloria SIMONCELLI, Vincenzo VILLANACCI
  Minerva Gastroenterology.2024;[Epub]     CrossRef
• Age over sex: evaluating gut microbiota differences in healthy Chinese populations
  Jiacheng Wu, Hexiao Shen, Yongling Lv, Jing He, Xiaotian Xie, Zhiyue Xu, Pengcheng Yang, Wei Qian, Tao Bai, Xiaohua Hou
  Frontiers in Microbiology.2024;[Epub]     CrossRef
• Clinical outcomes amongst elderly patients with inflammatory bowel disease
  Vithoosharan Sivanathan, Chamara Basnayake, William Connell, Emily Wright, John Nik Ding, Ola Niewadomski, Annalise Stanley, Amy Wilson‐O'Brien, Stephanie Fry, Tamie Samyue, Mark Lust, Emma Flanagan, Alexander J. V. Thompson, Michael A. Kamm
  Internal Medicine Journal.2023; 53(10): 1866.     CrossRef
• Non-neoplastic disorders in an aging gut: concise review
  Saurabh Dawra, Pradeep Behl, Sharad Srivastava, Manish Manrai, Alok Chandra, Anupam Kumar, Ankit Kumar, Manveer Singh Tevatia
  The Egyptian Journal of Internal Medicine.2023;[Epub]     CrossRef
• Enfermedad Inflamatoria Intestinal en el adulto mayor: Características clínicas y manejo en un hospital de referencia
  Juan Eloy Paredes Méndez, Sonia Irene Pérez Junes, Henry Tomás Vargas Marcacuzco, Edith Melissa Villafuerte Méndez
  Revista de Gastroenterología del Perú.2023; 43(1): 13.     CrossRef
• Clinical spectrum of elderly-onset inflammatory bowel disease in India
  Yogesh Kumar Gupta, Arshdeep Singh, Vikram Narang, Vandana Midha, Ramit Mahajan, Varun Mehta, Dharmatma Singh, Namita Bansal, Madeline Vithya Barnaba Durairaj, Amit Kumar Dutta, Ajit Sood
  Intestinal Research.2023; 21(2): 216.     CrossRef
• A new face of old cells: An overview about the role of senescence and telomeres in inflammatory bowel diseases
  Michał Sienkiewicz, Kamila Sroka, Agata Binienda, Diana Jurk, Jakub Fichna
  Ageing Research Reviews.2023; 91: 102083.     CrossRef
• Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review
  Mythili Menon Pathiyil, Anuraag Jena, Arvind Kumar Venkataramana Raju, Tina Aswani Omprakash, Vishal Sharma, Shaji Sebastian
  The Lancet Gastroenterology & Hepatology.2023; 8(12): 1143.     CrossRef
• Relation of geriatric nutritional risk index with clinical risks in elderly‐onset ulcerative colitis
  Masaaki Higashiyama, Shunsuke Komoto, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi, Soichiro Miura, Ryota Hokari
  Journal of Gastroenterology and Hepatology.2021; 36(1): 163.     CrossRef
• Atopic dermatitis does not increase the risk of inflammatory bowel disease: A nationwide cohort study
  Yu‐Ching Weng, Chao‐Kuei Juan, Hsiu J. Ho, Yi‐Ling Chang, Chun‐Ying Wu, Yi‐Ju Chen
  The Journal of Dermatology.2021; 48(2): 168.     CrossRef
• Common Diarrheal Illnesses in the Elderly
  Enad Dawod, Carl V. Crawford
  Clinics in Geriatric Medicine.2021; 37(1): 103.     CrossRef
• Inflammatory Bowel Disease: Managing Complex Patients
  Paula Miksa, Shane Ryan Apperley
  Physician Assistant Clinics.2021; 6(4): 655.     CrossRef
• The dietary practices and beliefs of people living with older-onset inflammatory bowel disease
  Benjamin Crooks, Ravi Misra, Naila Arebi, Klaartje Kok, Matthew J. Brookes, John McLaughlin, Jimmy K. Limdi
  European Journal of Gastroenterology & Hepatology.2021; 33(1S): e442.     CrossRef
• Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management
  G. Pellino, D. S. Keller, G. M. Sampietro, V. Annese, M. Carvello, V. Celentano, C. Coco, F. Colombo, N. Cracco, F. Di Candido, M. Franceschi, S. Laureti, G. Mattioli, L. Pio, G. Sciaudone, G. Sica, V. Villanacci, R. Zinicola, S. Leone, S. Danese, A. Spin
  Techniques in Coloproctology.2020; 24(2): 105.     CrossRef
• Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools
  Richard C. Cabot, Eric S. Rosenberg, Virginia M. Pierce, David M. Dudzinski, Meridale V. Baggett, Dennis C. Sgroi, Jo-Anne O. Shepard, Kathy M. Tran, Emily K. McDonald, Tara Corpuz, Hacho B. Bohossian, Emily W. Lopes, Lauren A. Roller, Ashwin N. Ananthakr
  New England Journal of Medicine.2020; 382(11): 1042.     CrossRef
• Elderly-onset vs adult-onset ulcerative colitis: a different natural history?
  Irene Zammarchi, Francesco Lanzarotto, Rosanna Cannatelli, Francesca Munari, Federica Benini, Alessandro Pozzi, Alberto Lanzini, Chiara Ricci
  BMC Gastroenterology.2020;[Epub]     CrossRef
• Association between inflammatory bowel disease and bullous pemphigoid: a population-based case–control study
  Yi-Ju Chen, Chao-Kuei Juan, Yun-Ting Chang, Chun-Ying Wu, Hsiu J. Ho, Hsiao-Ching Tseng
  Scientific Reports.2020;[Epub]     CrossRef
• Dietary Support in Elderly Patients with Inflammatory Bowel Disease
  Piotr Eder, Alina Niezgódka, Iwona Krela-Kaźmierczak, Kamila Stawczyk-Eder, Estera Banasik, Agnieszka Dobrowolska
  Nutrients.2019; 11(6): 1421.     CrossRef
• Exploring the therapeutic potential of sodium benzoate in acetic acid-induced ulcerative colitis in rats
  Deepali Walia, Gurpreet Kaur, Amteshwar Singh Jaggi, Anjana Bali
  Journal of Basic and Clinical Physiology and Pharmacology.2019;[Epub]     CrossRef

Faecal microbiota transplantation (FMT) has recently re-emerged as a viable therapeutic option for colonic disorders. Its efficacy has been proved in the treatment of Clostridium difficile infection which has encouraged research into the use of FMT for other disorders involving gut dysbiosis, such as ulcerative colitis (UC), a chronic inflammatory disease characterized by relapsing and remitting colonic inflammation. Although the FMT protocol for C. difficile treatment is well established, there are numerous additional factors to consider when applying FMT to treat inflammatory diseases. Various studies have attempted to address these factors but technical inconsistency between reports has resulted in a failure to achieve clinically significant findings. Case reports of FMT in UC have shown favorable outcomes yet demonstrating these effects on a larger scale has proved difficult. The following review aims to explore these issues and to analyze why they may be hindering the progression of FMT therapy in UC.

Citations

Citations to this article as recorded by  

• The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis
  Adam Saleh, Shyon Parsa, Manuel Garza, Eamonn M.M. Quigley, Bincy P. Abraham
  Digestive Diseases.2023; 41(4): 656.     CrossRef
• Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches
  Jana Štofilová, Monika Kvaková, Anna Kamlárová, Emília Hijová, Izabela Bertková, Zuzana Guľašová
  Biomedicines.2022; 10(9): 2236.     CrossRef
• Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience
  M.C. Flux, Christopher A. Lowry
  Neurobiology of Disease.2020; 135: 104578.     CrossRef
• In Situ Profiling of the Three Dominant Phyla Within the Human Gut Using TaqMan PCR for Pre-Hospital Diagnosis of Gut Dysbiosis
  Young Jae Jo, Setu Bazie Tagele, Huy Quang Pham, YeonGyun Jung, Jerald Conrad Ibal, SeungDae Choi, Gi-Ung Kang, Sowon Park, Yunkoo Kang, Seung Kim, Hong Koh, Jae-Ho Shin
  International Journal of Molecular Sciences.2020; 21(6): 1916.     CrossRef
• Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
  Xiao Yan Guo, Xin Juan Liu, Jian Yu Hao
  Journal of Digestive Diseases.2020; 21(3): 147.     CrossRef
• Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability
  Stephanie A. Flowers, Shubha Bhat, James C. Lee
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2020; 40(7): 704.     CrossRef
• Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis
  Ajit Sood, Ramit Mahajan, Garima Juyal, Vandana Midha, Charanpreet Singh Grewal, Varun Mehta, Arshdeep Singh, Mohan C Joshi, Vikram Narang, Kirandeep Kaur, Hasrat Sidhu
  Intestinal Research.2019; 17(1): 78.     CrossRef
• Multi-session fecal microbiota transplantation using colonoscopy has favorable outcomes for the treatment of steroid-dependent ulcerative colitis
  Young-Seok Cho
  Intestinal Research.2019; 17(1): 6.     CrossRef
• Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis
  Xiao Ding, Qianqian Li, Pan Li, Ting Zhang, Bota Cui, Guozhong Ji, Xiang Lu, Faming Zhang
  Drug Safety.2019; 42(7): 869.     CrossRef

Citations

Citations to this article as recorded by  

• Early course of newly diagnosed moderate‐to‐severe ulcerative colitis in Korea: Results from a hospital‐based inception cohort study (MOSAIK)
  Jin Young Yoon, Jae Myung Cha, Chang Kyun Lee, Young Sook Park, Kyu Chan Huh, Jeong Eun Shin, You Sun Kim, Chang Soo Eun, Soon Man Yoon, Jae Hee Cheon, Young Soo Park, Byong Duk Ye, YoungJa Lee, Youngdoe Kim, Hyo Jong Kim
  Journal of Gastroenterology and Hepatology.2021; 36(8): 2149.     CrossRef
• VALIDation of the IBD-Disk Instrument for Assessing Disability in Inflammatory Bowel Diseases in a French Cohort: The VALIDate Study
  Catherine Le Berre, Mathurin Flamant, Guillaume Bouguen, Laurent Siproudhis, Marie Dewitte, Nina Dib, Elodie Cesbron-Metivier, Thomas Goronflot, Matthieu Hanf, Pierre-Antoine Gourraud, Elise Kerdreux, Alexandra Poinas, Arnaud Bourreille, Caroline Trang-Po
  Journal of Crohn's and Colitis.2020; 14(11): 1512.     CrossRef

Citations

Citations to this article as recorded by  

• Mucosal and Transmural Healing and Long-term Outcomes in Crohn’s Disease
  Bruce E Sands, Silvio Danese, J Casey Chapman, Khushboo Gurjar, Stacy Grieve, Deepika Thakur, Jenny Griffith, Namita Joshi, Kristina Kligys, Axel Dignass
  Inflammatory Bowel Diseases.2025; 31(3): 857.     CrossRef
• Is infliximab therapy currently relevant in patients with inflammatory bowel diseases? (review)
  T. L. Alexandrov, B. A. Vykova
  Koloproktologia.2024; 23(2): 173.     CrossRef
• Expression of inflammatory mediators in biofilm samples and clinical association in inflammatory bowel disease patients—a preliminary study
  Mayte Buchbender, Jakob Fehlhofer, Peter Proff, Tobias Möst, Jutta Ries, Matthias Hannig, Markus F. Neurath, Madline Gund, Raja Atreya, Marco Kesting
  Clinical Oral Investigations.2022; 26(2): 1217.     CrossRef
• Microbiota and Drug Response in Inflammatory Bowel Disease
  Martina Franzin, Katja Stefančič, Marianna Lucafò, Giuliana Decorti, Gabriele Stocco
  Pathogens.2021; 10(2): 211.     CrossRef
• Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease
  Eran Zittan, A. Hillary Steinhart, Pavel Goldstein, Raquel Milgrom, Ian M. Gralnek, Mark S. Silverberg
  Clinical and Translational Gastroenterology.2021; 12(10): e00401.     CrossRef
• Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients
  So Yoon Choi, Young Ok Choi, Yon Ho Choe, Ben Kang
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Clinical and laboratory markers associated with anti-TNF-alpha trough levels and anti-drug antibodies in patients with inflammatory bowel diseases
  Ana B. Grinman, Maria das Graças C. de Souza, Eliete Bouskela, Ana Teresa P. Carvalho, Heitor S. P. de Souza
  Medicine.2020; 99(10): e19359.     CrossRef
• Changes in the Intestinal Microbiota of Patients with Inflammatory Bowel Disease with Clinical Remission during an 8-Week Infliximab Infusion Cycle
  Gyeol Seong, Namil Kim, Je-Gun Joung, Eun Ran Kim, Dong Kyung Chang, Jongsik Chun, Sung Noh Hong, Young-Ho Kim
  Microorganisms.2020; 8(6): 874.     CrossRef
• Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events
  Mitchell R. K. L. Lie, Emma Paulides, C. Janneke van der Woude
  International Journal of Colorectal Disease.2020; 35(8): 1489.     CrossRef
• Association of Infliximab Levels With Mucosal Healing Is Time-Dependent in Crohn’s Disease: Higher Drug Exposure Is Required Postinduction Than During Maintenance Treatment
  Ting Feng, Baili Chen, Bella Ungar, Yun Qiu, Shenghong Zhang, Jinshen He, Sinan Lin, Yao He, Zhirong Zeng, Shomron Ben-Horin, Minhu Chen, Ren Mao
  Inflammatory Bowel Diseases.2019; 25(11): 1813.     CrossRef
• Mucosal healing in inflammatory bowel disease: Expanding horizon
  Jimil Shah, Manik Lal Thakur, Usha Dutta
  Indian Journal of Gastroenterology.2019; 38(2): 98.     CrossRef

Citations

Citations to this article as recorded by  

• Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
  Seung Hwan Shin, Kyunghwan Oh, Sung Noh Hong, Jungbok Lee, Shin Ju Oh, Eun Soo Kim, Soo-Young Na, Sang-Bum Kang, Seong-Joon Koh, Ki Bae Bang, Sung-Ae Jung, Sung Hoon Jung, Kyeong Ok Kim, Sang Hyoung Park, Suk-Kyun Yang, Chang Hwan Choi, Byong Duk Ye
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Factors predicting clinical and endoscopic remission with placebo therapy in East Asian patients with ulcerative colitis: a systematic review and meta-analysis
  Jian Zeng, Zhong Wang, Xiao-Jun Yang
  European Journal of Clinical Pharmacology.2022; 78(7): 1069.     CrossRef
• Personalized medicine in inflammatory bowel disease: Perspectives on Asia
  Su Hyun Park, Sang Hyoung Park
  Journal of Gastroenterology and Hepatology.2022; 37(8): 1434.     CrossRef
• Safety and efficacy of long‐term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open
  Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Hyo Jong Kim, Byong Duk Ye, Shoko Arai, Masato Hoshi, Hirotoshi Yuasa, Junichi Tabira, Shigeyuki Toyoizumi, Nanzhi Shi, Joon‐suk Woo, Toshifumi Hibi
  Journal of Gastroenterology and Hepatology.2022; 37(10): 1884.     CrossRef
• Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
  Soo-Young Na, You Sun Kim
  The Korean Journal of Internal Medicine.2022; 37(5): 906.     CrossRef
• Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis
  Brittany N. Palasik, Hongmei Wang
  Journal of Pharmacy Practice.2021; 34(6): 913.     CrossRef
• Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
  Shu-Chen Wei, Jose Sollano, Yee Tak Hui, Wei Yu, Paul V. Santos Estrella, Lyndon John Q. Llamado, Nana Koram
  Expert Review of Gastroenterology & Hepatology.2021; 15(3): 275.     CrossRef
• Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
  Toshifumi Hibi, Isao Kamae, Philippe Pinton, Lyann Ursos, Ryuichi Iwakiri, Greg Hather, Haridarshan Patel
  Intestinal Research.2021; 19(1): 53.     CrossRef
• Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
  Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, Yasuo Suzuki, Yoshifumi Ohnishi, Noriyuki Fujii, Nobuko Matsushima, Richuan Zheng, Colleen W. Marano
  Intestinal Research.2021; 19(4): 386.     CrossRef
• Post-inflammatory Abdominal Pain in Patients with Inflammatory Bowel Disease During Remission: A Comprehensive Review
  Kazuya Takahashi, Iman Geelani Khwaja, Jocelyn Rachel Schreyer, David Bulmer, Madusha Peiris, Shuji Terai, Qasim Aziz
  Crohn's & Colitis 360.2021;[Epub]     CrossRef
• Multiple esophageal ulcers due to tofacitinib 10 mg twice daily for ulcerative colitis
  Keiichi Tominaga, Mimari Kanazawa, Kazuhiro Takenaka, Takanao Tanaka, Takeshi Sugaya, Koh Fukushi, Yuka Takagi, Kazunori Nagashima, Keiichiro Abe, Naoya Izawa, Kohei Tsuchida, Makoto Iijima, Kenichi Goda, Hidetsugu Yamagishi, Atsushi Irisawa
  Clinical Journal of Gastroenterology.2020; 13(3): 340.     CrossRef
• Interleukin 23 and autoimmune diseases: current and possible future therapies
  Ahmad Ismail Khaled Abdo, Gee Jun Tye
  Inflammation Research.2020; 69(5): 463.     CrossRef
• A Case of Lung Abscess Caused by Double Immunosuppressive Therapy to Treat Ulcerative Colitis
  Keiichi Tominaga, Mimari Kanazawa, Takanao Tanaka, Shunsuke Kojimahara, Takeshi Sugaya, Shoko Watanabe, Akira Yamamiya, Yuichi Majima, Makoto Iijima, Kenichi Goda, Atsushi Irisawa
  Medicina.2020; 56(11): 595.     CrossRef
• Inhibidores de la vía de señalización JAK-STAT en el tratamiento de las enfermedades inmunomediadas
  José M. Serra López-Matencio, Alberto Morell Baladrón, Santos Castañeda
  Medicina Clínica.2019; 152(9): 353.     CrossRef
• Interleukin-13: A promising therapeutic target for autoimmune disease
  Yan-Mei Mao, Chan-Na Zhao, Jing Leng, Rui-Xue Leng, Dong-Qing Ye, Song Guo Zheng, Hai-Feng Pan
  Cytokine & Growth Factor Reviews.2019; 45: 9.     CrossRef
• JAK-STAT inhibitors for the treatment of immunomediated diseases
  José M. Serra López-Matencio, Alberto Morell Baladrón, Santos Castañeda
  Medicina Clínica (English Edition).2019; 152(9): 353.     CrossRef
• Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience
  Ferdinando D’Amico, Tommaso Lorenzo Parigi, Gionata Fiorino, Laurent Peyrin-Biroulet, Silvio Danese
  Therapeutic Advances in Gastroenterology.2019;[Epub]     CrossRef
• Inhibitors of the Janus Kinases
  Elisabetta Antonelli, Gabriele Torti, Gabrio Bassotti
  Journal of Clinical Gastroenterology.2019; 53(9): 635.     CrossRef
• Novel oral-targeted therapies for mucosal healing in ulcerative colitis
  Elisabetta Antonelli, Vincenzo Villanacci, Gabrio Bassotti
  World Journal of Gastroenterology.2018; 24(47): 5322.     CrossRef

Citations

Citations to this article as recorded by  

• Effects of Administration of Prebiotics Alone or in Combination with Probiotics on In Vitro Fermentation Kinetics, Malodor Compound Emission and Microbial Community Structure in Swine
  Maro Lee, Yeonjae Choi, Joel Bayo, Andrew Wange Bugenyi, Yangseon Kim, Jaeyoung Heo
  Fermentation.2023; 9(8): 716.     CrossRef
• Statistical Optimization of Culture Conditions for Lactobacillus Strains using Response Surface Methodology
  Young Min Hwang, Hee-Seok Lee
  Journal of Food Hygiene and Safety.2023; 38(5): 338.     CrossRef
• The correlation of the fecal microbiome with the biochemical profile during menopause: a Brazilian cohort study
  Thayane Christine Alves da Silva, Jennefer Aparecida dos Santos Gonçalves, Laura Alves Cota e Souza, Angélica Alves Lima, R. Guerra-Sá
  BMC Women's Health.2022;[Epub]     CrossRef
• The Effect of Kefir Supplementation on Improving Human Endurance Exercise Performance and Antifatigue
  Mon-Chien Lee, Wei-Lun Jhang, Chia-Chia Lee, Nai-Wen Kan, Yi-Ju Hsu, Chin-Shan Ho, Chun-Hao Chang, Yi-Chen Cheng, Jin-Seng Lin, Chi-Chang Huang
  Metabolites.2021; 11(3): 136.     CrossRef
• Space, time and captivity: quantifying the factors influencing the fecal microbiome of an alpine ungulate
  Sarah E Haworth, Kevin S White, Steeve D Côté, Aaron B A Shafer
  FEMS Microbiology Ecology.2019;[Epub]     CrossRef
• Isolation and characterization of five novel probiotic strains from Korean infant and children faeces
  Sun-Young Kook, Eui-Chun Chung, Yaelim Lee, Dong Wan Lee, Seokjin Kim, Sudarshan Kumar
  PLOS ONE.2019; 14(10): e0223913.     CrossRef
• Characteristics of Faecal Microbiota in Korean Patients withClostridioides difficile-associated Diarrhea
  Yong Duk Jeon, Hea Won Ann, Woon Ji Lee, Jun Hyoung Kim, Hye Seong, Jung Ho Kim, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Joon Sup Yeom, Dongeun Yong, Kyungwon Lee, Jun Yong Choi
  Infection & Chemotherapy.2019; 51(4): 365.     CrossRef

Citations

Citations to this article as recorded by  

• The gut wall’s potential as a partner for precision oncology in immune checkpoint treatment
  Sara Hone Lopez, Mathilde Jalving, Rudolf S.N. Fehrmann, Wouter B. Nagengast, Elisabeth G.E. de Vries, Jacco J. de Haan
  Cancer Treatment Reviews.2022; 107: 102406.     CrossRef
• Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S‐methyltransferase inhibition
  Hiromu Morikubo, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Satoshi Kuronuma, Osamu Takeuchi, Tenyo Shiba, Hiroki Kiyohara, Mao Matsubayashi, Shintaro Sagami, Masaru Nakano, Osamu Ikezaki, Tadakazu Hisamatsu, Yoichi Tanaka, Toshifumi Hibi
  Journal of Gastroenterology and Hepatology.2021; 36(8): 2116.     CrossRef
• Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis
  Brigida Barberio, Jonathan P Segal, M Nabil Quraishi, Christopher J Black, Edoardo V Savarino, Alexander C Ford
  Journal of Crohn's and Colitis.2021; 15(7): 1184.     CrossRef
• Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
  Hiroshi Nakase, Motoi Uchino, Shinichiro Shinzaki, Minoru Matsuura, Katsuyoshi Matsuoka, Taku Kobayashi, Masayuki Saruta, Fumihito Hirai, Keisuke Hata, Sakiko Hiraoka, Motohiro Esaki, Ken Sugimoto, Toshimitsu Fuji, Kenji Watanabe, Shiro Nakamura, Nagamu I
  Journal of Gastroenterology.2021; 56(6): 489.     CrossRef
• Outcomes of a drug shortage requiring switching in patients with ulcerative colitis
  Daniel R van Langenberg, Richard Kai-Yuan Cheng, Mayur Garg
  World Journal of Gastrointestinal Pathophysiology.2020; 11(2): 32.     CrossRef
• Comparative assessment of budesonide‐MMX and mesalamine in active, mild‐to‐moderate ulcerative colitis: A systematic review and network meta‐analysis
  Stefanos Bonovas, Georgios K. Nikolopoulos, Daniele Piovani, Marien González‐Lorenzo, Katerina Pantavou, Theodore Lytras, Laurent Peyrin‐Biroulet, Silvio Danese
  British Journal of Clinical Pharmacology.2019; 85(10): 2244.     CrossRef
• Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents
  Eriko Yasutomi, Sakiko Hiraoka, Shumpei Yamamoto, Shohei Oka, Mami Hirai, Yasushi Yamasaki, Toshihiro Inokuchi, Hideaki Kinugasa, Masahiro Takahara, Keita Harada, Jun Kato, Hiroyuki Okada
  Journal of Clinical Medicine.2019; 8(12): 2109.     CrossRef
• Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
  Seong Ran Jeon
  Intestinal Research.2018; 16(2): 163.     CrossRef

Citations

Citations to this article as recorded by  

• Association of Clostridium difficile infection with clinical outcomes of patients with inflammatory bowel disease: A meta-analysis
  Hai-Xin Qi, Qi Wang, Gui-Qun Zhou
  World Journal of Gastrointestinal Surgery.2025;[Epub]     CrossRef
• Low prevalence of Clostridioides difficile infection in acute severe ulcerative colitis: A retrospective cohort study from northern India
  Sandeep Mundhra, David Thomas, Saransh Jain, Pabitra Sahu, Sudheer Vuyyuru, Peeyush Kumar, Bhaskar Kante, Rajesh Panwar, Peush Sahni, Rama Chaudhry, Prasenjit Das, Govind Makharia, Saurabh Kedia, Vineet Ahuja
  Indian Journal of Gastroenterology.2023; 42(3): 411.     CrossRef
• The Prevalence and Risk Factors of Clostridioides difficile Infection in Inflammatory Bowel Disease: 10-Year South Korean Experience Based on the National Database
  Eun Mi Song, Arum Choi, Sukil Kim, Sung Hoon Jung
  Journal of Korean Medical Science.2023;[Epub]     CrossRef
• Clostridioides Infection in Patients with Inflammatory Bowel Disease
  Mi Rae Lee, Eun Soo Kim
  The Korean Journal of Gastroenterology.2022; 80(2): 66.     CrossRef
• Clostridium difficile in ulcerative colitis; a retrospective study
  O. V. Knyazev, A. V. Kagramanova, M. E. Chernova, I. A. Koroleva, A. I. Parfenov
  Almanac of Clinical Medicine.2018; 46(5): 474.     CrossRef

Citations

Citations to this article as recorded by  

• A Case of Ulcerative Colitis with Acute Pericarditis after Dose Escalation of Mesalazine
  Jun Wada, Kazumasa Kawashima, Michio Onizawa, Naohiko Gunji, Yu Watahiki, Chiharu Sakuma, Mai Murakami, Tomoaki Mochimaru, Shunsuke Miura, Hiromasa Ohira
  Internal Medicine.2025;[Epub]     CrossRef
• Novel desensitization therapy of mesalamine intolerance in patients with ulcerative colitis
  Kenji Kinoshita, Shintaro Sawaguchi, Kai Toyoshima, Sonoe Yoshida, Takahiro Yamamura, Kosuke Nagai, Ikko Tanaka, Kazuteru Hatanaka, Yoshiya Yamamoto, Hirohito Naruse, Takehiko Katsurada, Naoya Sakamoto
  Gastroenterología y Hepatología.2025; : 502347.     CrossRef
• Hydralazine‐Induced ANCA Vasculitis Presenting With Pericarditis: A Novel Case and Literature Review
  Ahmed Sami Hammami, Osejie Oriaifo, Sinda Hidri, Sukhvir Singh, Husam El Sharu, Joshua Peltz, Soroush Nomigolzar, Kunjan Udani, Aiden Abidov
  Case Reports in Cardiology.2025;[Epub]     CrossRef
• Secondary loss‐of‐response associated with intolerance to Janus kinase inhibitor in a boy with ulcerative colitis
  Yuka Minoura, Koji Yokoyama, Yuko Okada, Shinya Fukuda, Hideki Kumagai
  Pediatrics International.2025;[Epub]     CrossRef
• Drug-induced Interstitial Nephritis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid
  Daichi Hayashi, Tsutomu Nishida, Naoto Osugi, Yasuo Kusunoki, Satoru Okabe, Yoshifumi Fujii, Dai Nakamatsu, Kengo Matsumoto, Masashi Yamamoto, Koji Fukui
  Internal Medicine.2024; 63(8): 1081.     CrossRef
• Hemodialysis patients with allergic reactions to dialysate whose symptoms improved without dialysate change：Two case reports
  Hisato Shima, Yoko Nishiuchi, Yoshio Fukata, Takuya Okamoto, Manabu Tashiro, Tomoko Inoue, Hiroyasu Bando, Hiroyuki Azuma, Naohito Iwasaka, Takuji Ohara, Toshio Doi, Kazuyoshi Okada, Jun Minakuchi
  Nihon Toseki Igakkai Zasshi.2024; 57(1): 23.     CrossRef
• Clinical Features of Thiopurine-Induced Acute Pancreatitis: Comparison Between Patients With and Without Inflammatory Bowel Disease
  Tomofumi Oizumi, Yosuke Toya, Shunichi Yanai, Takayuki Matsumoto
  Crohn's & Colitis 360.2024;[Epub]     CrossRef
• Allergic clinical symptoms and distribution of stimulation index of drug lymphocyte stimulation test for local anesthetics
  Yukiko Baba, Yu Sato, Ken Takahashi, Takaya Ito, Ryo Wakita, Shigeru Maeda
  Oral and Maxillofacial Surgery.2024;[Epub]     CrossRef
• Lymphocyte stimulation test for diagnosing hen’s egg yolk–induced enterocolitis syndrome
  Naoki Kajita, Go Kusakawa, Hiroki Seto, Keiko Hirao, Shoko Yokoyama, Emi Morikawa, Kumiko Morita, Masami Narita, Koichi Yoshida
  Journal of Allergy and Clinical Immunology: Global.2023; 2(4): 100138.     CrossRef
• Risk factors for intolerance of oral 5‐aminosalicylic acid preparations in pediatric ulcerative colitis
  Naoki Abe, Naomi Iwata, Ryuhei Yasuoka, Daisuke Nishida, Asami Oohara, Haruna Nakaseko, Shiro Sugiura, Shinji Kawabe
  Pediatrics International.2023;[Epub]     CrossRef
• Pulmonary Manifestations of Inflammatory Bowel Disease and Treatment Strategies
  Subha Ghosh, Himanshu Deshwal, Rebecca Haraf, Shine Raju, Mnahi Bin Saeedan, Pralay Sarkar, Thomas Gildea, Carol F. Farver, Atul C. Mehta
  CHEST Pulmonary.2023; 1(3): 100018.     CrossRef
• Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
  Yohei Mikami, Junya Tsunoda, Shohei Suzuki, Ichiro Mizushima, Hiroki Kiyohara, Takanori Kanai
  Digestion.2023; 104(1): 58.     CrossRef
• The Forefront of Drug Therapy for Ulcerative Colitis
  Tadakazu Hisamatsu, Daisuke Saito, Minoru Matsuura
  Nippon Daicho Komonbyo Gakkai Zasshi.2023; 76(10): 580.     CrossRef
• Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease
  Kaoru Suzuki, Yoichi Kakuta, Takeo Naito, Tetsuya Takagawa, Hiroyuki Hanai, Hiroshi Araki, Yu Sasaki, Hirotake Sakuraba, Makoto Sasaki, Tadakazu Hisamatsu, Satoshi Motoya, Takayuki Matsumoto, Motoyuki Onodera, Yoh Ishiguro, Hiroshi Nakase, Akira Andoh, Sa
  Inflammatory Bowel Diseases.2022; 28(1): 21.     CrossRef
• A complicated case of Serratia marcescens catheter-related bloodstream infection misdiagnosed as hypersensitivity reactions to bicarbonate dialysate containing acetate
  Hisato Shima, Takuya Okamoto, Tomoko Inoue, Manabu Tashiro, Yusaku Tanaka, Norimichi Takamatsu, Seiichiro Wariishi, Kazuhiko Kawahara, Kazuyoshi Okada, Jun Minakuchi
  CEN Case Reports.2022; 11(1): 55.     CrossRef
• Cyanamide-induced oral lichenoid drug reaction: Case report and literature review
  Yurie Akiyama, Yusuke Oomura, Masahiro Okamura, Chiho Hiraga-Kondo, Taiki Suzuki, Kazumichi Sato, Shinichi Takahashi, Takeshi Nomura
  Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.2022; 34(2): 209.     CrossRef
• 5‐Aminosalicylic acid‐induced pericarditis in pediatric Crohn’s disease
  Yuki Toguchi, Kahoru Fukuoka‐Araki, Kei Matayoshi, Saori Kinjo, Toshifumi Yodoshi
  Pediatrics International.2022;[Epub]     CrossRef
• Hematochezia Due to Panitumumab-induced Colitis with Vitamin K Deficiency
  Hotaka Tamura, Koji Nakashima, Naomi Uchiyama, Souichiro Ogawa, Hiroshi Hatada, Naoki Yoshida, Keisuke Uchida, Yoshinori Ozono, Hiroyuki Tanaka, Koji Yamamto, Hiroshi Kawakami
  Internal Medicine.2022; 61(10): 1503.     CrossRef
• A Case of Stevens–Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative Colitis
  Mimari Kanazawa, Keiichi Tominaga, Akira Kanamori, Takanao Tanaka, Satoshi Masuyama, Shoko Watanabe, Keiichiro Abe, Akira Yamamiya, Kenichi Goda, Atsushi Irisawa
  Medicina.2022; 58(2): 276.     CrossRef
• A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease
  Kevin Cesa, Catherine Cunningham, Tyler Harris, Whitney Sunseri
  Cureus.2022;[Epub]     CrossRef
• Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis
  Yuki Minagawa, Kazuhiko Uchiyama, Tomohisa Takagi, Katsura Mizushima, Kohei Asaeda, Mariko Kajiwara-Kubota, Saori Kashiwagi, Yuma Hotta, Makoto Tanaka, Ken Inoue, Osamu Dohi, Tetsuya Okayama, Naohisa Yoshida, Kazuhiro Katada, Kazuhiro Kamada, Takeshi Ishi
  Journal of Clinical Biochemistry and Nutrition.2022; 71(3): 249.     CrossRef
• Multicenter survey on mesalamine intolerance in patients with ulcerative colitis
  Sakiko Hiraoka, Akiko Fujiwara, Tatsuya Toyokawa, Reiji Higashi, Yuki Moritou, Shinjiro Takagi, Kazuhiro Matsueda, Seiyuu Suzuki, Jiro Miyaike, Toshihiro Inokuchi, Masahiro Takahara, Jun Kato, Hiroyuki Okada
  Journal of Gastroenterology and Hepatology.2021; 36(1): 137.     CrossRef
• Maternal mesalazine-induced neonatal gastrointestinal bleeding
  Kohichiroh Nii, Kaoru Okazaki, Hitoshi Okada, Toru Kuboi
  BMJ Case Reports.2021; 14(4): e238743.     CrossRef
• Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
  Hiroshi Nakase, Motoi Uchino, Shinichiro Shinzaki, Minoru Matsuura, Katsuyoshi Matsuoka, Taku Kobayashi, Masayuki Saruta, Fumihito Hirai, Keisuke Hata, Sakiko Hiraoka, Motohiro Esaki, Ken Sugimoto, Toshimitsu Fuji, Kenji Watanabe, Shiro Nakamura, Nagamu I
  Journal of Gastroenterology.2021; 56(6): 489.     CrossRef
• Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
  Ji Young Chang, Jae Hee Cheon
  Precision and Future Medicine.2021; 5(4): 151.     CrossRef
• Hypersensitivity reactions to bicarbonate dialysate containing acetate: a case report with literature review
  Yoko Nishiuchi, Hisato Shima, Yoshio Fukata, Tomohiro Tao, Takuya Okamoto, Norimichi Takamatsu, Kazuyoshi Okada, Jun Minakuchi
  CEN Case Reports.2020; 9(3): 243.     CrossRef
• Anaphylaxis to three humanized antibodies for severe asthma: a case study
  Koichi Jingo, Norihiro Harada, Toshihiko Nishioki, Masahiro Torasawa, Tomoko Yamada, Tetsuhiko Asao, Haruhi Takagi, Tomohito Takeshige, Jun Ito, Kazuhisa Takahashi
  Allergy, Asthma & Clinical Immunology.2020;[Epub]     CrossRef
• Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report
  Yoshinori Arai, Maiko Ogawa, Fumitsugu Yamane, Natsuki Sumiyoshi, Rikako Arimoto, Yoshitaka Ando, Daisuke Endo, Tatsuya Nakada, Ichiro Sugawara, Hiroshi Yokoyama, Keiko Shimoyama, Hiroko Inomata, Yosuke Kawahara, Masayuki Kato, Seiji Arihiro, Atsushi Hoka
  Clinical Journal of Gastroenterology.2020; 13(6): 1200.     CrossRef
• Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
  Satohiro Matsumoto, Hirosato Mashima
  Scientific Reports.2020;[Epub]     CrossRef
• Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis
  Rumiko Tsuboi, Satohiro Matsumoto, Hiroyuki Miyatani, Hirosato Mashima
  Internal Medicine.2019; 58(5): 649.     CrossRef
• Allergic reactions to small-molecule drugs: Will we move from reaction to prediction?
  Mark F Bonfiglio, David M Weinstein
  American Journal of Health-System Pharmacy.2019; 76(9): 574.     CrossRef

Citations

Citations to this article as recorded by  

• Diagnosis and Classification of Fistula from Inflammatory Bowel Disease and Inflammatory Bowel Disease-Related Surgery
  Sarah Householder, Joseph A. Picoraro
  Gastrointestinal Endoscopy Clinics of North America.2022; 32(4): 631.     CrossRef

Citations

Citations to this article as recorded by  

• Analyzing the landscape of coeliac crisis in adult and paediatric populations: A systematic review and meta-analysis
  Arkadeep Dhali, Rick Maity, Hareesha Rishab Bharadwaj, Syed Hasham Ali, Muhammad Hamza Shah, David Surendran Sanders
  Digestive and Liver Disease.2025;[Epub]     CrossRef
• Clinicopathologic Analysis of Malabsorption Syndrome in a Tertiary Care Center in South India
  Nidhya Ganesan, S. Shrinnivi, R. Shivani, R. K. Kartikayan
  Medical Journal of Dr. D.Y. Patil Vidyapeeth.2024; 17(3): 616.     CrossRef
• Prevalence of haplotype DQ2/DQ8 and celiac disease in children with type 1 diabetes
  Agnieszka Zubkiewicz-Kucharska, Tatiana Jamer, Joanna Chrzanowska, Katarzyna Akutko, Tomasz Pytrus, Andrzej Stawarski, Anna Noczyńska
  Diabetology & Metabolic Syndrome.2022;[Epub]     CrossRef
• Celiac crisis, a rare occurrence in adult celiac disease: A systematic review
  Daniel Vasile Balaban, Alina Dima, Ciprian Jurcut, Alina Popp, Mariana Jinga
  World Journal of Clinical Cases.2019; 7(3): 311.     CrossRef
• The spectrum of clinical and subclinical endocrinopathies in treatment-naïve patients with celiac disease
  Vipin Gupta, Alka Singh, Rajesh Khadgawat, Ashish Agarwal, Asif Iqbal, Wajiha Mehtab, P.K. Chaturvedi, Vineet Ahuja, Govind K. Makharia
  Indian Journal of Gastroenterology.2019; 38(6): 518.     CrossRef

Citations

Citations to this article as recorded by  

• Strategies to improve screening colonoscopy quality for the prevention of colorectal cancer
  Joo Hye Song, Eun Ran Kim
  The Korean Journal of Internal Medicine.2024; 39(4): 547.     CrossRef
• A study on the related influencing factors of the quality of bowel preparation and the compliance of middle-aged and elderly patients for colonoscopy
  Shanshan Chen, Tingting Zhang, Saie Zhu, Yi Zhou
  Current Medical Research and Opinion.2024; 40(9): 1545.     CrossRef
• Performance of Computer-Aided Detection and Quality of Bowel Preparation: A Comprehensive Analysis of Colonoscopy Outcomes
  Dalton A. Norwood, Shyam Thakkar, Amanda Cartee, Fayez Sarkis, Tatiana Torres-Herman, Eleazar E. Montalvan-Sanchez, Kirk Russ, Patricia Ajayi-Fox, Anam Hameed, Ramzi Mulki, Sergio A. Sánchez-Luna, Douglas R. Morgan, Shajan Peter
  Digestive Diseases and Sciences.2024; 69(10): 3681.     CrossRef
• Optimization of colonoscopy quality: Comprehensive review of the literature and future perspectives
  Wen‐Feng Hsu, Han‐Mo Chiu
  Digestive Endoscopy.2023; 35(7): 822.     CrossRef
• Risk Factors Associated with Painful Colonoscopy and Prolonged Cecal Intubation Time in Female Patients
  Yasuhiko Hamada, Kyosuke Tanaka, Yohei Ikenoyama, Noriyuki Horiki, Junya Tsuboi, Reiko Yamada, Misaki Nakamura, Hayato Nakagawa
  Journal of the Anus, Rectum and Colon.2023; 7(3): 168.     CrossRef
• The effect of educational compilation through video tutorials and visual AIDS on the quality of bowel preparation in patients undergoing colonoscopy
  Jahanbakhsh Amirarsalani, Leyla Alilu, Masoumeh Hemmati-Maslakpak, Javad Rasouli
  Acta Facultatis Medicae Naissensis.2023; 40(3): 307.     CrossRef
• A predictive model for early death in elderly colorectal cancer patients: a population-based study
  Qi Wang, Kexin Shen, Bingyuan Fei, Hai Luo, Ruiqi Li, Zeming Wang, Mengqiang Wei, Zhongshi Xie
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Regression and Random Forest Machine Learning Have Limited Performance in Predicting Bowel Preparation in Veteran Population
  Jacob E. Kurlander, Akbar K. Waljee, Stacy B. Menees, Rachel Lipson, Alex N. Kokaly, Andrew J. Read, Karmel S. Shehadeh, Amy Cohn, Sameer D. Saini
  Digestive Diseases and Sciences.2022; 67(7): 2827.     CrossRef
• Comparison of 2 L Polyethylene Glycol Plus Ascorbic Acid and 4 L Polyethylene Glycol in Elderly Patients Aged 60–79: A Prospective Randomized Study
  Sung Hoon Jung, Chul-Hyun Lim, Tae-Geun Gweon, Jinsu Kim, Jung Hwan Oh, Kyu-Tae Yoon, Jee Young An, Jeong‑Seon Ji, Hwang Choi
  Digestive Diseases and Sciences.2022; 67(10): 4841.     CrossRef
• Quality indicators in colonoscopy: the chasm between ideal and reality
  Su Bee Park, Jae Myung Cha
  Clinical Endoscopy.2022; 55(3): 332.     CrossRef
• Efficacy, safety and tolerability of oral sulphate tablet for bowel preparation in patients with inflammatory bowel disease: A multicentre randomized controlled study
  Kyeong Ok Kim, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Eun Soo Kim, Yun Jin Chung, Byung Ik Jang, Sung Kook Kim, Chang Heon Yang
  Journal of Crohn's and Colitis.2022; 16(11): 1706.     CrossRef
• Comparison of Two Types of 1-L Polyethylene Glycol-ascorbic Acid as Colonoscopic Bowel Preparation: A Prospective Randomized Study
  Suh Hyun Choi, Won Eui Yoon, Seung Hyuk Kim, Hee Jun Myung, Seo Hyun Kim, Soon Oh So, Se Hun Kim, Hyun Mi Lee, Yeoun Jung Oh, Jeong Seop Moon, Tae Yeong Park, You Sun Kim
  The Korean Journal of Gastroenterology.2022; 80(2): 85.     CrossRef
• Comparative Effectiveness of Commercial Bowel Preparations in Ambulatory Patients Presenting for Screening or Surveillance Colonoscopy
  Shashank Sarvepalli, Ari Garber, Carol A. Burke, Niyati Gupta, Mounir Ibrahim, John McMichael, Gareth Morris-Stiff, Amit Bhatt, John Vargo, Maged Rizk, Michael B. Rothberg
  Digestive Diseases and Sciences.2021; 66(6): 2059.     CrossRef
• Quality Improvement of Bowel Preparation for Screening Colonoscopies: A Study of Hospital Team Resource Management in Taiwan
  Chen-Shuan Chung, Chih-Ming Lin, Ming-Shu Chen
  Quality Management in Health Care.2021; 30(2): 127.     CrossRef
• Postgastrectomy gastric cancer patients are at high risk for colorectal neoplasia: a case control study
  Tae-Geun Gweon, Kyu-Tae Yoon, Chang Hyun Kim, Jin-Jo Kim
  Intestinal Research.2021; 19(2): 239.     CrossRef
• How to Choose the Optimal Bowel Preparation Regimen for Colonoscopy
  Ji Eun Na, Eun Ran Kim
  The Ewha Medical Journal.2021; 44(4): 122.     CrossRef
• Factors related to Bowel Cleanliness of Colonoscopy Examinees
  Yohan Lee, Haejung Lee
  Korean Journal of Adult Nursing.2021; 33(6): 545.     CrossRef
• Comparison of bowel-cleansing efficacy of split-dose and same-day dose bowel preparation for afternoon colonoscopy in patients with gastrectomy: a prospective randomized study
  Tae-Geun Gweon, Cheal Wung Huh, Jeong Seon Ji, Chang Hyun Kim, Jin-Jo Kim, Seung-Man Park
  Surgical Endoscopy.2020; 34(10): 4413.     CrossRef
• Combination of bisacodyl suppository and 1 L polyethylene glycol plus ascorbic acid is a non‐inferior and comfortable regimen compared to 2 L polyethylene glycol plus ascorbic acid
  Sun Hwa Kim, Eun Ran Kim, Kyunga Kim, Tae Jun Kim, Sung Noh Hong, Dong Kyung Chang, Young‐Ho Kim
  Digestive Endoscopy.2020; 32(4): 600.     CrossRef
• Efficacy and Patient Tolerability Profiles of Probiotic Solution with Bisacodyl Versus Conventional Cleansing Solution for Bowel Preparation: A Prospective, Randomized, Controlled Trial
  Youn I Choi, Jong-Joon Lee, Jun-Won Chung, Kyoung Oh Kim, Yoon Jae Kim, Jung Ho Kim, Dong Kyun Park, Kwang An Kwon
  Journal of Clinical Medicine.2020; 9(10): 3286.     CrossRef
• Educational virtual reality videos in improving bowel preparation quality and satisfaction of outpatients undergoing colonoscopy: protocol of a randomised controlled trial
  Yi Zhao, Feng Xie, Xiaoyin Bai, Aiming Yang, Dong Wu
  BMJ Open.2019; 9(8): e029483.     CrossRef
• Impact of diet restriction on bowel preparation for colonoscopy
  Seung-Joo Nam, Young Jin Kim, Bora Keum, Jae Min Lee, Seung Han Kim, Hyuk Soon Choi, Eun Sun Kim, Yeon Seok Seo, Yoon Tae Jeen, Hong Sik Lee, Hoon Jai Chun, Soon Ho Um, Chang Duck Kim
  Medicine.2018; 97(41): e12645.     CrossRef

Citations

Citations to this article as recorded by  

• Retrograde colon imaging through colonic transendoscopic enteral tubing helps to confirm the cause of difficult colonoscopy: a case report
  Xiaomeng Jiang, Runqing Wang, Haibo Sun, Faming Zhang
  Therapeutic Advances in Gastrointestinal Endoscopy.2024;[Epub]     CrossRef
• Causes of intraprocedural discomfort in colonoscopy: a review and practical tips
  Jabed F. Ahmed, Ara Darzi, Lakshmana Ayaru, Nisha Patel
  Therapeutic Advances in Gastrointestinal Endoscopy.2024;[Epub]     CrossRef
• Research on driving force of capsule endoscope in fluid
  Zhifan Teng, Jianhua Liu, Hongbo Sun, Quanyue Liu, Yujia Zhai, Qiuliang Wang
  Archive of Applied Mechanics.2023; 93(12): 4387.     CrossRef
• Robot-assisted magnetic capsule endoscopy; navigating colorectal inclinations
  Salman Mahmood, Sebastian Schostek, Marc O. Schurr, Jacob Bergsland, Ilangko Balasingham, Erik Fosse
  Minimally Invasive Therapy & Allied Technologies.2022; 31(6): 930.     CrossRef
• Magnetic endoscopic imaging as a rational investment for specific colonoscopies: a systematic review and meta-analysis
  Xiangzhou Tan, Weimin Yang, Doerte Wichmann, Changhao Huang, Benedikt Mothes, K.E. Grund, Zhikang Chen, Zihua Chen
  Expert Review of Gastroenterology & Hepatology.2021; 15(4): 447.     CrossRef
• Screening colonoscopy: The present and the future
  Chelsea V Hayman, Dinesh Vyas
  World Journal of Gastroenterology.2021; 27(3): 233.     CrossRef
• Transparent cap‐assisted, water‐exchange colonoscopy in previous incomplete difficult colonoscopy patients: A retrospective study
  Lien‐Fu Lin, Pi‐Teh Huang
  Advances in Digestive Medicine.2020; 7(3): 118.     CrossRef
• Can water insufflation and carbon dioxide overcome the difficulties of colonoscope insertion?
  Choong-Kyun Noh, Kee Myung Lee
  Intestinal Research.2018; 16(2): 166.     CrossRef

Patients with inflammatory bowel disease (IBD) have been reported to have an increased risk of thromboembolism. Cerebral venous thrombosis (CVT) is a rare but serious extraintestinal manifestation of IBD. Due to its highly variable manifestation and low incidence, CVT is not usually readily recognized by physicians. Herein, we report a case of a 35-year-old male presenting with CVT associated with ulcerative colitis (UC). The patient was admitted with chief complaints of bloody diarrhea that had started 3 days prior. Sigmoidoscopy showed hyperemic and edematous mucosa, friability, and shallow ulcers from the sigmoid colon to the rectum suggestive of IBD. Three days later, the patient started complaining of a headache, and gradually developed a decreased level of consciousness. Magnetic resonance imaging of the brain revealed CVT with hemorrhagic infarctions. An angiogram was obtained to evaluate the extent of CVT, and anticoagulation therapy was initiated with intravenous heparin. During hospitalization, he was diagnosed with UC and treated with 5-aminosalicylic acid. After discharge, the patient was recovered without neurological deficit, and remission of UC was also obtained. The presence of headache or acute worsening of neurological status in a patient with IBD should alert the health professionals about the possibility of CVT.

Citations

Citations to this article as recorded by  

• Digit Necrosis After Hand Surgery in Pregnancy: A Case Report
  Natalia Ziolkowski, Jana Dengler, Cory S Goldberg
  Plastic Surgery Case Studies.2021;[Epub]     CrossRef
• Cerebral venous thrombosis as presenting manifestation of inflammatory bowel disease (IBD)
  Katie Stamp, Alison Pattinson, Paul Maliakal, Thekootu Nandakumar, Shaji Sebastian
  GastroHep.2019; 1(1): 45.     CrossRef

Citations

Citations to this article as recorded by  

• Perioperative optimization of Crohn's disease
  Chun‐Chi Lin, Hung‐Hsin Lin, Hui‐Chuen Chen, Nai‐Chia Chen, I‐Lun Shih, Ji‐Shiang Hung, Te‐Cheng Yueh, Feng‐Fan Chiang, Ping‐Wei Lin, Yuan‐Yao Tsai, Shu‐Chen Wei
  Annals of Gastroenterological Surgery.2023; 7(1): 10.     CrossRef
• Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study
  Yasuhiro Aoki, Hiroki Kiyohara, Yohei Mikami, Kosaku Nanki, Takaaki Kawaguchi, Yusuke Yoshimatsu, Shinya Sugimoto, Tomohisa Sujino, Kaoru Takabayashi, Naoki Hosoe, Haruhiko Ogata, Yasushi Iwao, Takanori Kanai
  Intestinal Research.2023; 21(3): 318.     CrossRef
• Incidence and risk factors for venous thrombosis among patients with inflammatory bowel disease in China: a multicenter retrospective study
  Jing Liu, Xiang Gao, Ye Chen, Qiao Mei, Liangru Zhu, Jiaming Qian, Pinjin Hu, Qian Cao
  Intestinal Research.2021; 19(3): 313.     CrossRef
• Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study
  Wei-Chen Lin, Meng-Tzu Weng, Chien-Chih Tung, Yuan-Ting Chang, Yew-Loong Leong, Yu-Ting Wang, Horng-Yuan Wang, Jau-Min Wong, Shu-Chen Wei
  Journal of Translational Medicine.2019;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Behçet's syndrome
  Giacomo Emmi, Alessandra Bettiol, Gülen Hatemi, Domenico Prisco
  The Lancet.2024; 403(10431): 1093.     CrossRef
• Current pharmacological solutions for Behçet’s syndrome
  Yesim Ozguler, Sinem Nihal Esatoglu, Gulen Hatemi
  Expert Opinion on Pharmacotherapy.2023; 24(2): 221.     CrossRef
• Treatment Options in Pediatric Behçet’s Disease
  Teresa Giani, Angela Flavia Luppino, Giovanna Ferrara
  Pediatric Drugs.2023; 25(2): 165.     CrossRef
• Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
  Jae Hee Cheon
  Journal of Rheumatic Diseases.2021; 28(1): 4.     CrossRef
• Long-term outcome and predictors of remission in Behçet’s disease in daily practice
  Aida Malek Mahdavi, Alireza Khabbazi, Mehrzad Hajialilo
  Modern Rheumatology.2021; 31(6): 1148.     CrossRef
• Lactobacillus plantarum CBT LP3 ameliorates colitis via modulating T cells in mice
  Da Hye Kim, Soochan Kim, Jae Bum Ahn, Jae Hyeon Kim, Hyun Woo Ma, Dong Hyuk Seo, Xiumei Che, Ki Cheong Park, Jeong Yong Jeon, Sang Yong Kim, Han Cheol Lee, Jae-Young Lee, Tae Il Kim, Won Ho Kim, Seung Won Kim, Jae Hee Cheon
  International Journal of Medical Microbiology.2020; 310(2): 151391.     CrossRef
• Successful combination therapy using adalimumab and 5-aminosalicylic acid for a resistant case of intestinal Behçet’s disease
  H. J. Kim, K.‑t. Kim, S.-G. Lee, Y. Kim
  Zeitschrift für Rheumatologie.2020; 79(7): 702.     CrossRef
• Safety of systemic treatments for Behçet’s syndrome
  Giuseppe Lopalco, Donato Rigante, Antonio Lopalco, Giacomo Emmi, Vincenzo Venerito, Antonio Vitale, Giovanna Capozio, Nunzio Denora, Luca Cantarini, Florenzo Iannone
  Expert Opinion on Drug Safety.2020; 19(10): 1269.     CrossRef
• Update on the treatment of Behçet’s syndrome
  Sinem Nihal Esatoglu, Gulen Hatemi
  Internal and Emergency Medicine.2019; 14(5): 661.     CrossRef

Citations

Citations to this article as recorded by  

• Author's Reply
  Sakiko Hiraoka, Jun Kato, Hiroyuki Okada
  Intestinal Research.2018; 16(2): 321.     CrossRef